These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8060810)
1. Myocardial function and postmortem myocardial histology in children given anthracycline therapy for cancer. Pihkala J; Sariola H; Saarinen UM Pediatr Hematol Oncol; 1994; 11(3):259-69. PubMed ID: 8060810 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Iarussi D; Auricchio U; Agretto A; Murano A; Giuliano M; Casale F; Indolfi P; Iacono A Mol Aspects Med; 1994; 15 Suppl():s207-12. PubMed ID: 7752832 [TBL] [Abstract][Full Text] [Related]
3. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. Lipshultz SE; Colan SD; Gelber RD; Perez-Atayde AR; Sallan SE; Sanders SP N Engl J Med; 1991 Mar; 324(12):808-15. PubMed ID: 1997853 [TBL] [Abstract][Full Text] [Related]
4. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents]. Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932 [TBL] [Abstract][Full Text] [Related]
5. Cardiac function in Wilms' tumor survivors. Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343 [TBL] [Abstract][Full Text] [Related]
6. Functional myocardial impairment in children treated with anthracyclines for cancer. Yeung ST; Yoong C; Spink J; Galbraith A; Smith PJ Lancet; 1991 Apr; 337(8745):816-8. PubMed ID: 1672914 [TBL] [Abstract][Full Text] [Related]
7. [Serial determination of anthracycline poisoning in children]. Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725 [TBL] [Abstract][Full Text] [Related]
8. Exposure to anthracyclines during childhood causes cardiac injury. Lipshultz SE Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284 [TBL] [Abstract][Full Text] [Related]
9. Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404. Asselin BL; Devidas M; Chen L; Franco VI; Pullen J; Borowitz MJ; Hutchison RE; Ravindranath Y; Armenian SH; Camitta BM; Lipshultz SE J Clin Oncol; 2016 Mar; 34(8):854-62. PubMed ID: 26700126 [TBL] [Abstract][Full Text] [Related]
10. Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress. Lang D; Hilger F; Binswanger J; Andelfinger G; Hartmann W Eur J Pediatr; 1995 May; 154(5):340-5. PubMed ID: 7641762 [TBL] [Abstract][Full Text] [Related]
11. Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients. Elbl L; Hrstkova H; Tomaskova I; Blazek B; Michalek J Eur J Pediatr; 2005 Nov; 164(11):678-84. PubMed ID: 16044276 [TBL] [Abstract][Full Text] [Related]
12. Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children. Lewis AB; Crouse VL; Evans W; Takahashi M; Siegel SE Pediatrics; 1981 Jul; 68(1):67-72. PubMed ID: 6941210 [TBL] [Abstract][Full Text] [Related]
13. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125 [TBL] [Abstract][Full Text] [Related]
14. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study. Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647 [TBL] [Abstract][Full Text] [Related]
15. Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy. Santin JC; Deheinzelin D; Junior SP; Lopes LF; de Camargo B J Pediatr Hematol Oncol; 2007 Nov; 29(11):761-5. PubMed ID: 17984694 [TBL] [Abstract][Full Text] [Related]
16. Anthracycline-induced cardiomyopathy in children: a report of six cases. Dearth J; Osborn R; Wilson E; Kelly D; Mantle J; Rogers E; Malluh A; Crist W Med Pediatr Oncol; 1984; 12(1):54-8. PubMed ID: 6583470 [TBL] [Abstract][Full Text] [Related]
17. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354 [TBL] [Abstract][Full Text] [Related]
18. Echocardiographic assessment of anthracycline cardiotoxicity in children. Lewis AB; Pilkington R; Takahashi M; Siegel SE Med Pediatr Oncol; 1978; 5(1):167-75. PubMed ID: 745585 [No Abstract] [Full Text] [Related]
19. [Clinical usefulness of quantitative two-dimensional echocardiographic analysis of segmental kinesis of the left ventricle in monitoring of patients with neoplasms treated with anthracyclines]. Pisacane C; Iarussi D; Buono S; Gualtieri S; Coppolino P; Iacono A G Ital Cardiol; 1991 Dec; 21(12):1259-67. PubMed ID: 1818000 [TBL] [Abstract][Full Text] [Related]
20. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. Pihkala J; Saarinen UM; Lundström U; Virtanen K; Virkola K; Siimes MA; Pesonen E Eur J Cancer; 1996 Jan; 32A(1):97-103. PubMed ID: 8695252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]